Consumer Health Cancer / Immunology
The companies will work collaboratively to seek the regulatory approval for Foundation Medicine assays which detect mutations including BRAFV600E to i...
November 16, 2023 | News
Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...
November 14, 2023 | News
In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is...
November 13, 2023 | News
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...
November 13, 2023 | News
“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...
November 09, 2023 | News
ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations,...
November 08, 2023 | News
These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...
November 06, 2023 | News
With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...
November 06, 2023 | News
For the first time, Nataliya courageously shared her story of overcoming breast cancer, inspiring others with her inner power and resilience. Five years la...
October 31, 2023 | Opinion
This strategic collaboration combines GC Aesthetics' 40 years’ experience in design, manufacturing, and distribution of Silicone Breast Implants with...
October 27, 2023 | News
In a groundbreaking move, Wellesta Holdings and Ancom Truelife have come together in a pioneering partnership aimed at revolutionizing breast cancer detect...
October 23, 2023 | News
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
October 20, 2023 | News
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...
October 19, 2023 | News
By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for im...
October 16, 2023 | News
Most Read
Bio Jobs
News
Editor Picks